ارتباط بین پلی مورفیسمهای miR-152 و miR-148a با سن شروع و مراحل پیشرفت سرطان پستان در جمعیت اصفهان
Authors
Abstract:
Abstract Background: Breast cancer is the most common cancer among women. Polymorphisms of micro RNA genes such as microRNA 152 and microRNA 148a that they are involved in cell proliferation, angiogenesis and apoptosis could be a potential factor for increasing risk of breast cancer and its development. So, the aim of this study is to investigate the association between polymorphisms of these micro-RNAs and age of onset and progression of breast cancer. Methods: This case-control study was conducted on 100 patients of breast cancer and 100 healthy women. The routine clinical tests were performed in studied patients regularly. After genotyping using RFLP-PCR and Tetra primer ARMS-PCR techniques, subjects of this study were categorized into three genotypes including AA,AG and GG for the miR-148a polymorphism and TT,TC and CC for the miR152 polymorphism. The collected data through the SISA website and chi-square tests were analyzed. Findings: The results show that the miR-148a and miR152 polymorphisms reduce age of onset of cancer, but this is not statistically significant (miR152: OR=2.16, P=0.06), (miR-148a: OR=2.54, P=0.06). There is also no significant association between these polymorphisms and stages of cancer progression were observed (miR148a: OR=1.16, P=0.09); )miR152: OR=0.47, P=0.13). Conclusion: It seems that the G and T alleles can be as a risk factor for the reduction of age of onset and breast cancer progression in Isfahan population. But to determine the alleles as biology risk factors further studies and more research is needed.
similar resources
Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation.
microRNAs (miRs) are endogenous small non-coding RNAs that are aberrantly expressed in various carcinomas. miR-152 and miR-148a have not been comprehensively investigated in ovarian cancer. Thus, the aim of this study was to identify the role of miR-152 and miR-148a in epithelial ovarian cancer. Total RNA was extracted from tissues of 78 patients ...
full textبررسی بیان miR-520d در سرطان پستان
Background: Breast cancer is the most common cancer in women. Non-coding RNAs especially miRNAs have important regulatory roles in cancer. MiRNAs are 21-24 nucleotides which have different levels of expression between tumors and normal tissues. In this study, we have analyzed expression level of miR-520d in three different groups of breast cancer.Methods: Fifty nine samples were divided into di...
full textmiR-148a promotes myogenic differentiation
Jing Zhang E-mail: [email protected] Zheng-zhou Ying E-mail: [email protected] Zhong-lin Tang Corresponding author. Fax/ Tel: +86 01062813822 Email addresses: [email protected] Liang-qi Long Co-corresponding author E-mail: [email protected] Kui Li E-mail: [email protected] To whom correspondence should be addressed: Zhong-lin Tang, Ph.D, Department of Gen...
full textThe Role of Mir-148a in Cancer
MicroRNAs (miRNAs) are highly conserved noncoding RNAs of about 19-25 nucleotides. Through specifically pairing with complementary sites in 3' untranslated regions (UTRs) of target mRNAs, they mediate post-transcriptional silencing. MicroRNAs have been implicated in many physiological processes including proliferation, differentiation, development, apoptosis, and metabolism. In recent years man...
full textبررسی بیان miR-21 و miR-221 در سرطان معده و ارتباط آن با ژنهای RECK وCDKN1B
سابقه و هدف: مطالعات اخیر بیانگر نقش کلیدی miR-221 و miR-21 در سرطان معده می باشند . هر چند دانش ما در مورد مکانیسم مولکولی عملکرد miR-221 و miR- 21 در سرطان بطور کلی و در سرطان معده بطور خاص محدود است. در این مطالعه دو microRNA بالقوه انکوژن (miR-221 و miR-21) انتخاب شده تا ارتباط سطوح بیان این microRNA ها و ژن های هدف آنها در بافت سالم و سرطانی معده مقایسه شوند. هدف این مطالعه بررسی ارتباط بی...
full textبررسی بیان mir-۵۲۰d در سرطان پستان
زمینه و هدف: ریز rnaها 21 تا 24 نوکلئوتید دارند و بیان بعضی از آن ها در بین بافت نرمال و توموری متفاوت است. در این مطالعه ما بیان mir-520d را در بین گروه های توموری سرطان پستان با نمونه نرمال کنار آن مورد بررسی قرار دادیم.روش بررسی: 59 نمونه تومور سرطان پستان در سه گروه مختلف قرار داده شدند. در گروه اول نمونه های دارای رسپتور استروژن مثبت و یا رسپتور پروژسترون مثبت قرار گرفتند. در گروه دوم نمون...
full textMy Resources
Journal title
volume 40 issue 4
pages 187- 191
publication date 2017-01
By following a journal you will be notified via email when a new issue of this journal is published.
No Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023